Sign Up Today and Learn More About Hrain Biotechnology Stock

Invest in or calculate the value of your shares in Hrain Biotechnology or other pre-IPO companies through EquityZen's platform.

Get Started

Hrain Biotechnology Stock

Hrain Biotechnology is adhering to the concept of treating diseases and saving people.

About Hrain Biotechnology Stock

Founded

2015

Hrain Biotechnology is a tumor immunotherapy technology developer, using the tumor immunotherapy technology CAR-T to provide cancer patients with precise treatment based on biological and cellular technology, and built centers in Beijing, Jiangsu, Chongqing, Henan and other places. Clinical trial platform.

Hrain Biotechnology Press Mentions

Stay in the know about the latest news on Hrain Biotechnology

Hrain Biotechnology Management

Leadership team at Hrain Biotechnology

Chief Scientific Officer

Wang Pin

Locked Features

Join now and verify your accreditation status to gain access to:

  • Hrain Biotechnology current valuation
  • Hrain Biotechnology stock price
  • Available deals in Hrain Biotechnology and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Hrain Biotechnology stock?

Accredited investors can buy pre-IPO stock in companies like Hrain Biotechnology through EquityZen funds. These investments are made available by existing Hrain Biotechnology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Hrain Biotechnology stock?

Shareholders can sell their Hrain Biotechnology stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."